Compounds > arotinolol
Page last updated: 2024-10-22

arotinolol and Hypertension, Malignant

arotinolol has been researched along with Hypertension, Malignant in 2 studies

arotinolol: structure given in first source; arotinolol is the (+-)-isomer

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamoto, H2
Nemoto, H2
Sugahara, S2
Okada, H2
Suzuki, H2

Trials

1 trial available for arotinolol and Hypertension, Malignant

ArticleYear
Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1999, Volume: 22, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Calcium Channel Blockers; Dru

1999

Other Studies

1 other study available for arotinolol and Hypertension, Malignant

ArticleYear
Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2000, Volume: 23, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Biopsy; Blood Pressure; Calcium Channel Blockers; Creatinine; De

2000